 |
|
A new radiation therapy treatment developed for head and neck cancer patients
August 17, 2007Large doses of radiation can be targeted to cancer using a well-tolerated boron compound
Most head-and-neck cancers that recur locally after prior full-dose conventional radiation therapy respond to Boron Neutron Capture Therapy (BNCT). These results were obtained in a Phase I/II study at the Helsinki University Hospital, Finland. The scientific director of the research program, professor Heikki Joensuu, University of Helsinki, considers the results clinically significant and very interesting. They open a new field for BNCT, since thus far BNCT has been evaluated only in the treatment of some brain tumours.
The follow-up results of 12 patients diagnosed with cancer of the head-and-neck and treated in a prospective clinical trial were reported in the International Journal of Radiation Oncology, Biology & Physics (online version available: www.redjournal.org). All patients had cancer of the head-and-neck that had recurred locally after surgery and conventional radiation therapy. Ten out of the 12 patients had substantial tumour shrinkage following BNCT, and in 7 cases the tumour disappeared completely. Adverse effects of treatment were moderate and resembled those of conventional radiation therapy.
The study has been expanded, and up to 30 subjects will now be allowed to enter the study protocol.
Boron neutron capture therapy (BNCT) is a form of targeted radiation treatment for cancer. It is still considered experimental. In this method a boron-containing compound (boronophenylalanine) is first infused into a peripheral vein, following which the compound accumulates in cancer tissue. Cancer is subsequently irradiated with neutrons obtained from a nuclear reactor, which causes boron atoms to split within the cancerous tissue as a result from a boron neutron capture reaction. The resulting smaller particles cause a large radiation effect within the tumour tissue, which destroys cancer cells.
The technique allows targeting of a high dosage of radiation to the tumour while allowing sparing of the adjacent normal tissues from the highest doses of radiation. Boron-mediated targeting of radiation allows treatment of patients who can no longer be treated with conventional radiation therapy. BNCT is administered as single one-day treatment that may be repeated.
The study was sponsored by Boneca Corporation, the spinoff company operating on the medical campus of the Helsinki University and the University Central Hospital (www.boneca.fi). The treatments are carried out in collaboration with the Department of Oncology, Helsinki University Central Hospital, at the BNCT facility constructed at the VTT research nuclear reactor site located at Otaniemi, Espoo. The neutron radiation used in the treatment is provided by VTT.
Boneca Corporation's clinical research program includes also a phase I/II study that evaluates BNCT in the treatment of primary glioblastoma (a highly malignant brain tumour) and another clinical trial that assesses safety and efficacy of BNCT in the treatment of glioblastomas and anaplastic astrocytomas (a type of brain tumour) that have recurred after conventional radiation therapy.
"Our plan is to investigate BNCT in the treatment of cancers located elsewhere in the body that cannot be effectively managed by any known treatment," says professor Heikki Joensuu.
"The current treatment is a result of a long period of research, a proof of academic expertise, and a model for effective collaboration between Helsinki University Central Hospital, University of Helsinki, VTT Technical Research Centre of Finland, and the company", says Boneca Corporation's managing director Markku Pohjola.
University of Helsinki
The study has been expanded, and up to 30 subjects will now be allowed to enter the study protocol.
Boron neutron capture therapy (BNCT) is a form of targeted radiation treatment for cancer. It is still considered experimental. In this method a boron-containing compound (boronophenylalanine) is first infused into a peripheral vein, following which the compound accumulates in cancer tissue. Cancer is subsequently irradiated with neutrons obtained from a nuclear reactor, which causes boron atoms to split within the cancerous tissue as a result from a boron neutron capture reaction. The resulting smaller particles cause a large radiation effect within the tumour tissue, which destroys cancer cells.
The technique allows targeting of a high dosage of radiation to the tumour while allowing sparing of the adjacent normal tissues from the highest doses of radiation. Boron-mediated targeting of radiation allows treatment of patients who can no longer be treated with conventional radiation therapy. BNCT is administered as single one-day treatment that may be repeated.
The study was sponsored by Boneca Corporation, the spinoff company operating on the medical campus of the Helsinki University and the University Central Hospital (www.boneca.fi). The treatments are carried out in collaboration with the Department of Oncology, Helsinki University Central Hospital, at the BNCT facility constructed at the VTT research nuclear reactor site located at Otaniemi, Espoo. The neutron radiation used in the treatment is provided by VTT.
Boneca Corporation's clinical research program includes also a phase I/II study that evaluates BNCT in the treatment of primary glioblastoma (a highly malignant brain tumour) and another clinical trial that assesses safety and efficacy of BNCT in the treatment of glioblastomas and anaplastic astrocytomas (a type of brain tumour) that have recurred after conventional radiation therapy.
"Our plan is to investigate BNCT in the treatment of cancers located elsewhere in the body that cannot be effectively managed by any known treatment," says professor Heikki Joensuu.
"The current treatment is a result of a long period of research, a proof of academic expertise, and a model for effective collaboration between Helsinki University Central Hospital, University of Helsinki, VTT Technical Research Centre of Finland, and the company", says Boneca Corporation's managing director Markku Pohjola.
University of Helsinki
Radiation Therapy Current Events and Radiation Therapy News RSSSurvival of head and neck cancer patients is greatly affected by coexisting ailments
Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.D., a head and neck specialist at Washington University School of Medicine in St. Louis, the Siteman Cancer Center and Barnes-Jewish Hospital.
Fat injections can improve breast reconstruction -- jury's out on augmentation
Injecting fat after breast reconstruction to correct implant wrinkling or dimpling may be safe and effective to improve breast shape.
OHSU Cancer Institute researcher: radiation, immunotherapy gives greater effectiveness
Oregon Health & Science University Cancer Institute researchers have found the right formula of radiation and immunotherapy for fighting lung cancer tumors in mice, which they hope will translate to better treatment in human lung cancers.
Cancer patients who receive neoadjuvant therapy followed by mastectomy may not need radiation
Early-stage breast cancer patients who exhibit limited lymph node involvement may not require post-surgery radiation therapy (RT) when they receive neoadjuvant chemotherapy before a mastectomy, according to researchers from The University of Texas M. D. Anderson Cancer Center.
OHSU Cancer Institute researchers study breathing during radiation
Oregon Health & Science University researchers have determined exactly how much breathing affects prostate movement during radiation treatment.
Whole brain radiation increases risk of learning and memory problems in cancer patients
Cancer patients who receive stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) for the treatment of metastatic brain tumors have more than twice the risk of developing learning and memory problems than those treated with SRS alone, according to new research from The University of Texas M. D. Anderson Cancer Center.
The effective chemoradiotherapy method for pancreatic cancer
Pancreatic cancer is the fifth most common cause of cancer death in Japan. The prognosis is extremely poor because it is difficult to detect this disease in the early stage and also the postoperative incidence of recurrence is still high, and we have not had any effective treatment for inoperable patients.
Study suggests some breast cancer patients facing radiation after a mastectomy may be over-treated
A new study suggests standard radiation therapy for some breast cancer patients may not be medically required and may, therefore, be causing unnecessary serious side effects such as lymphedema and pulmonary problems.
Proton therapy lowers chance of later cancers
Patients who are treated with proton therapy (a specialized type of external beam radiation therapy using protons rather than X-rays to treat cancer) decreases the risk of patients developing a secondary cancer by two-fold, compared to being treated with standard photon radiation treatment.
Many cancer patients receive insufficient pain management therapy
Pain is one of the most common symptoms of cancer patients, yet many of them do not receive adequate therapy for the pain caused by their disease or treatments, according to a study in the September 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
More Radiation Therapy Current Events and Radiation Therapy News Articles
 | The Physics of Radiation Therapy by Faiz M Khan, Faiz M. Khan This leading reference source devoted to radiation therapy physics is now in its Third Edition. Pertinent to the entire radiation oncology team, it is clinically oriented and presents practical aspects as well as underlying theory to clarify basic concepts. The format begins with underlying physics, then progresses to treatment planning, and ends with radiation. Contains an expanded focus with... |
| Portal Design in Radiation Therapy, 2nd ed by Byron G. Dasher; Anne Marie Vann Portal Design in Radiation Therapy, 2nd Edition contains over 120 explicit diagrams illustrating the anatomy and lymphatics included in typical treatment portals. In addition, CT and MR anatomy are included, as well as tissue tolerance charts. Descriptions of surrounding anatomy, routes of spread, technical aspects of portal design and typical doses employed for each tumor site are... | |
 | Radiation Therapy Physics by William R. Hendee, Geoffrey S. Ibbott, Eric G. Hendee The Third Edition of Radiation Therapy Physics addresses in concise fashion the fundamental diagnostic radiologic physics principles as well as their clinical implications. Along with coverage of the concepts and applications for the radiation treatment of cancer patients, the authors have included reviews of the most up-to-date instrumentation and critical historical links. The text includes... |
 | The Chemotherapy & Radiation Therapy Survival Guide (Chemotherapy and Radiation Therapy Survivor's Guide) by Judith McKay, Nancee Hirano |
 | The Physics of Three Dimensional Radiation Therapy: Conformal Radiotherapy, Radiosurgery and Treatment Planning (Medical Science) by S. Webb The Physics of Three Dimensional Radiation Therapy presents a broad study of the use of three-dimensional techniques in radiation therapy. These techniques are used to specify the target volume precisely and deliver radiation with precision to minimize damage to surrounding healthy tissue. The book discusses multimodality computed tomography, complex treatment planning software, advanced... |
 | Radiation Therapy Planning by Gunilla C. Bentel All new expanded edition provides step-by-step guidelines on performing the technical aspects of radiation therapy. Important new coverage includes treatment preparation, 3-D treatment planning, dosimetry, new technologies, documentation, and quality assurance. In addition, you'll find added treatment planning guidelines by body region, and an expanded art program including many new 4-color... |
 | Principles and Practice of Radiation Therapy by Charles M. Washington, Dennis T. Leaver Learn everything you need to know about radiation therapy with the only comprehensive text written for radiation therapy students by radiation therapists. Principles and Practice of Radiation Therapy is designed to help you understand cancer management, improve clinical techniques for delivering doses of radiation, and apply complex concepts to treatment planning and delivery. This edition... |
 | Coping With Chemotherapy and Radiation Therapy by Daniel Cukier New advances in treatment offer cancer patients more options than ever before. Coping with Chemotherapy and Radiation is an accessible, accurate guide to the latest developments in radiation therapy and chemotherapy. You will find important information on how chemotherapy and radiation treatments work; what to expect from treatments, how to alleviate common side effects, and... |
 | The Best News About Radiation Therapy: Everything You Need to Know About Your Treatment by Carol Kornmehl Dr. Carol Kornmehl guides patients through this intimidating process, explaining each step of the therapy and the results they can expect from there... |
 | Walter and Miller's Textbook of Radiotherapy: Radiation Physics, Therapy and Oncology by C. K. Bomford, I. H. Kunkler, S. B. Sherriff, J. Walter, H. Miller |
| © 2008 BrightSurf.com |